Skip to Content

Clinical Trials Details

Roche KAITLIN

Patient Information

Roche KAITLIN - A randomized, multicenter, open-label, Phase III trial comparing Trastuzumabplus Pertuzumab plus a Taxane following Anthracyclines versus Trastuzumab Emtansine plus Pertuzumab following Anthracyclines as Adjuvant Therapy in patients with operable Her2-positive primary breast cancer.

View more information about clinical trial - Roche KAITLIN

Study Number
Roche KAITLIN

Clinical Trial Categories

  • Breast Cancer - Adjuvant

Location

  • Cone Health Cancer Center at Wesley Long
    501 N. Elam Avenue
    Greensboro, NC 27403
    Main: 336-832-1100

Also in this Section